V, B., C, E., G, B., J, G., E, R., L, S., . . . JM, C. (2020). Quality of life, medication adherence and satisfaction with anticoagulant treatment (dabigatran vs vitamin K antagonists) according to thromboembolic risk. Data from the CAPANA study. International journal of clinical practice, 74(11), e13605. https://doi.org/10.1111/ijcp.13605
Chicago Style (17th ed.) CitationV, Barrios, et al. "Quality of Life, Medication Adherence and Satisfaction with Anticoagulant Treatment (dabigatran Vs Vitamin K Antagonists) According to Thromboembolic Risk. Data from the CAPANA Study." International Journal of Clinical Practice 74, no. 11 (2020): e13605. https://doi.org/10.1111/ijcp.13605.
MLA (9th ed.) CitationV, Barrios, et al. "Quality of Life, Medication Adherence and Satisfaction with Anticoagulant Treatment (dabigatran Vs Vitamin K Antagonists) According to Thromboembolic Risk. Data from the CAPANA Study." International Journal of Clinical Practice, vol. 74, no. 11, 2020, p. e13605, https://doi.org/10.1111/ijcp.13605.